Board Meeting14 Oct 2026, 08:20 pm
Sun Pharma Board Meeting on Oct 30 to Approve Unaudited Results
AI Summary
Sun Pharmaceutical Industries Ltd has announced that its Board of Directors will convene on October 30, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The trading window for the company's securities will remain closed from October 1, 2026, until 48 hours after the declaration of these results, closing on November 1, 2026.
Key Highlights
- Board meeting scheduled for October 30, 2026.
- To approve unaudited financial results for Q2 FY27 and H1 FY27.
- Results will be both standalone and consolidated.
- Trading window closure extended until November 1, 2026.
Price Impact
More from SUNPHARMA